(Q44678823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Fibroblast growth factor 23 in feline chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Harriet Syme

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

R F Geddes

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N C Finch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

11 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

Journal of Veterinary Internal Medicine

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

234-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

On the pathogenesis of the uremic state. An exposition of the "trade-off hypothesis".

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Phosphate homeostasis and the renal-gastrointestinal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Key elements of bioanalytical method validation for small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Determination of fibroblast growth factor 23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJVIM.12044

21 January 2018

Identifiers

DOI

10.1111/JVIM.12044

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23398216%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference